Literature DB >> 1659061

The HSV-1 latency associated transcript (LAT) variants 1704 and 1705 are glycoprotein C negative.

Z Wroblewska1, J G Spivack, J Otte, I Steiner, M Brown, A MacLean, N W Fraser.   

Abstract

The latency associated transcripts (LAT) of herpes simplex virus type 1 (HSV-1) are encoded by diploid genes that are expressed during latent infections. Two LAT variant viruses, 1704 and 1705, were compared with the parental strain 17+. Variant 1705 has a deletion affecting one copy of the LAT genes, expresses LATs during latent infection and reactivates normally. Variant 1704 has deletions affecting both LAT gene copies, does not express LATs during latent infection, and its reactivation is impaired (Steiner et al., 1989). Comparison of infected cell proteins by immunoprecipitation and Western blot analysis revealed one significant difference between HSV-1 strain 17+, 1704 and 1705; glycoprotein C (gC) was not synthesized by 1704 or 1705. Since both 1704 and 1705 are gC minus, the reactivation defect of 1704 is most likely related to the absence of the LATs, and not to the absence of gC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659061     DOI: 10.1016/0168-1702(91)90109-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia.

Authors:  D Goldenberg; N Mador; M J Ball; A Panet; I Steiner
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 2.  Molecular biology of herpes simplex virus type 1 latency in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

3.  In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.

Authors:  M D Trousdale; I Steiner; J G Spivack; S L Deshmane; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.